middle.news

CLINUVEL Files 20-F to Upgrade U.S. ADR Listing on Nasdaq

9:06am on Tuesday 16th of June, 2026 AEST Pharmaceuticals
Read Story

CLINUVEL Files 20-F to Upgrade U.S. ADR Listing on Nasdaq

9:06am on Tuesday 16th of June, 2026 AEST
Key Points
  • Public filing of Form 20-F with U.S. SEC
  • Plan to upgrade ADR from Level I to Level II
  • Intended Nasdaq listing of ADS under ticker CUVL
  • No new capital or shares to be issued
Read Story
middle.

Tap to Read

Tap the card to read the full analysis
about Clinuvel Pharmaceuticals (ASX:CUV)
OPEN ARTICLE